The Journal of Experimental Medicine
ReproCELL
  Home | Help | Feedback | Subscriptions | Archive | Search | Latest Articles

Published online 9 October 2006. doi:10.1084/jem.20061462
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 1260K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ejrnaes, M.
Right arrow Articles by von Herrath, M. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ejrnaes, M.
Right arrow Articles by von Herrath, M. G.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
© The Rockefeller University Press, 0022-1007
The Journal of Experimental Medicine


ARTICLE

Resolution of a chronic viral infection after interleukin-10 receptor blockade

Mette Ejrnaes1, Christophe M. Filippi1, Marianne M. Martinic1, Eleanor M. Ling1, Lisa M. Togher1, Shane Crotty2, and Matthias G. von Herrath1

1 Immune Regulation Lab – DI3 and 2 Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037

CORRESPONDENCE Matthias G. von Herrath: matthias{at}liai.org

A defining characteristic of persistent viral infections is the loss and functional inactivation of antiviral effector T cells, which prevents viral clearance. Interleukin-10 (IL-10) suppresses cellular immune responses by modulating the function of T cells and antigen-presenting cells. In this paper, we report that IL-10 production is drastically increased in mice persistently infected with lymphocytic choriomeningitis virus. In vivo blockade of the IL-10 receptor (IL-10R) with a neutralizing antibody resulted in rapid resolution of the persistent infection. IL-10 secretion was diminished and interferon {gamma} production by antiviral CD8+ T cells was enhanced. In persistently infected mice, CD8{alpha}+ dendritic cell (DC) numbers declined early after infection, whereas CD8{alpha} DC numbers were not affected. CD8{alpha} DCs supported IL-10 production and subsequent dampening of antiviral T cell responses. Therapeutic IL-10R blockade broke the cycle of IL-10–mediated immune suppression, preventing IL-10 priming by CD8{alpha} DCs and enhancing antiviral responses and thereby resolving infection without causing immunopathology.


Abbreviations used: BFA, Brefeldin A; HCV, hepatitis C virus; LCMV, lymphocytic choriomeningitis virus; PD-1, programmed death 1 receptor; TLR, Toll-like receptor.

M. Ejrnaes, C.M. Filippi, and M.M. Martinic contributed equally to this paper.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article

Curtailing infection
Ruth Williams
J. Exp. Med. 2006 203: 2393. [Full Text] [PDF]



This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search